Kenvue (KVUE) Stock Forecast & Price Target

$24.06 -0.18 (-0.74%)

(As of 02:34 PM ET)

Kenvue - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 12 Analyst Ratings

Sell
1

Hold
7

Buy
4

Based on 12 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 1 has given a sell rating, 7 have given a hold rating, and 4 have given a buy rating for KVUE.

Consensus Price Target

$22.64
-5.92% Downside

According to the 12 analysts' twelve-month price targets for Kenvue, the average price target is $22.64. The highest price target for KVUE is $27.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted downside of -5.92% from the current price of $24.06.

Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

KVUE Analyst Ratings Over Time

Type	Current Forecast 11/27/23 to 11/26/24	1 Month Ago 10/28/23 to 10/27/24	3 Months Ago 8/29/23 to 8/28/24	1 Year Ago 11/27/22 to 11/27/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)	8 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$22.64	$22.64	$22.64	$26.92
Forecasted Upside	-5.92% Downside	-0.02% Downside	4.22% Upside	33.52% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

2025: Digital Asset Insights You Need to Know (Ad)

Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.

Get your guide today!

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kenvue Stock vs. The Competition

Type	Kenvue	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.25	2.49	2.50
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-6.23% Downside	35.85% Upside	6.94% Upside
News Sentiment Rating	Positive News See Recent KVUE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/22/2024	Bank of America 4 of 5 stars		Boost Target	Buy ➝ Buy	$24.00 ➝ $27.00	+18.11%
10/11/2024	JPMorgan Chase & Co. 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$24.00 ➝ $25.00	+17.15%
9/24/2024	Jefferies Financial Group 2 of 5 stars		Initiated Coverage	Buy	$27.00	+17.29%
9/24/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$24.00	+4.26%
9/23/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $21.00	-8.77%
8/7/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$23.00 ➝ $24.00	+14.72%
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad) Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late.
8/7/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $22.00	+5.36%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$21.00 ➝ $20.00	+13.06%
5/8/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$20.00 ➝ $21.00	+3.09%
4/11/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$18.00	-11.02%
4/3/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Andersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy ➝ Neutral	$20.00	+5.24%
9/7/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$28.00	+25.06%
9/6/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
7/25/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
5/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$28.00	+6.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:02 PM ET.

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 22, 2024. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

Here are some ways that investors could benefit from investing in Kenvue Inc.:

Kenvue Inc. has recently received multiple upgrades from analysts, with Bank of America raising its price target to $27.00, indicating strong market confidence in the company's growth potential.
The current stock price of Kenvue Inc. is $23.78, which is close to its 12-month high of $24.13, suggesting that the stock is performing well and may continue to appreciate.
The company reported earnings per share (EPS) of $0.28, exceeding analysts' expectations of $0.27, which reflects strong operational performance and effective management.
Kenvue Inc. has a solid dividend yield of approximately 3.45%, providing investors with a steady income stream, which is particularly attractive in a low-interest-rate environment.
The company operates in three segments—Self Care, Skin Health and Beauty, and Essential Health—diversifying its revenue streams and reducing reliance on any single market segment.

Kenvue
Bear Case

Investors should be bearish about investing in Kenvue Inc. for these reasons:

Kenvue Inc. has a relatively high price-to-earnings (P/E) ratio of 43.27, which may indicate that the stock is overvalued compared to its earnings, potentially leading to a price correction.
The company’s revenue decreased by 0.4% year-over-year, which could signal challenges in maintaining growth and market share in a competitive environment.
With a dividend payout ratio of 149.09%, Kenvue Inc. is paying out more in dividends than it earns, which may not be sustainable in the long term and could lead to dividend cuts.
One analyst has rated the stock with a sell rating, indicating that there are concerns about the company's future performance among some market participants.
The stock has a beta of 1.36, suggesting higher volatility compared to the market, which could lead to greater risk for investors during market downturns.

KVUE Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $22.64, with a high forecast of $27.00 and a low forecast of $18.00.
: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last twelve months. There is currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
: According to analysts, Kenvue's stock has a predicted downside of -5.92% based on their 12-month stock forecasts.
: Over the previous 90 days, Kenvue's stock had 1 downgrade by analysts.
: Kenvue has been rated by research analysts at Bank of America, Jefferies Financial Group, JPMorgan Chase & Co., Piper Sandler, and Royal Bank of Canada in the past 90 days.
: Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.25 while the average consensus rating score for "consumer staples" companies is 2.49. Learn more on how KVUE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

This page (NYSE:KVUE) was last updated on 11/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kenvue (KVUE) Stock Forecast & Price Target